http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2252741-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00 |
| filingDate | 2003-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c873f32964dcf6a68a632db0687e006f |
| publicationDate | 2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2252741-C2 |
| titleOfInvention | Method for treating the biologically active points |
| abstract | FIELD: medicine. n SUBSTANCE: method involves exposing biologically active points electromagnetic radiation using source with radiation line spectrum having luminous body material radiation resonance line. When treating biologically active point of P1 (Zhong-fu), tin-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of E 25 (Tian-shu), zinc-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 12 (Zhong-wan), bismuth-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of F13 (Zhang-men), chrome-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 14 (Jui-cue), potassium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 4 (Guan-yuan), lead-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VC 3 (Zhong-ji), mercury-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of VB25 (Jing-men), arsenic-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of VC 5 (Shi-men), VC 17 (Tan-zhong), VC 12 (Zhong-wan), VC 7 (Yin-jiao), calcium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 24 (Ri-yue), 23 (Zhe-jin), osmium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active points of 1 Tian-chi, R 11 (Heng-gu), VC 17 (Tan-zhong), sodium-containing material is selected as the luminous body material of the line spectrum source. When treating biologically active point of 14 (Ci-men), gold-containing material is selected as the luminous body material of the line spectrum source. n EFFECT: enhanced effectiveness in treating biologically active points. |
| priorityDate | 2003-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.